Aviir Inc. announced that it will be extending its services with the comprehensive inherited cardiovascular disease genetic test menu. The tests cover the major causes of cardiomyopathies, arrhythmias, and other genetically transmitted disease that affect the heart and vasculature.
Each test is available for both individual and familial testing, and two comprehensive panels are available to check for undiagnosed arrhythmia or cardiomyopathy. The company utilizes targeted re-sequencing to determine if a patient has inherited DNA sequence variants that could place them at significant risk for sudden cardiac death.
Aviir’s proprietary MIRISK and MIRISK VP assessments identify individuals who are at high risk of experiencing a cardiac event over the next five years.
For more information call (888) 287-4217 or visit the Aviir website.